Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Sales: 2009-2019

Historic Return on Sales for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Sales fell 5.00% to 0.04% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.04%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.05% for FY2019, which is negligibly% changed negligibly from last year.
  • Per Neurocrine Biosciences' latest filing, its Return on Sales stood at 0.05% for FY2019, which was up 0.37% from 0.05% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Return on Sales registered a high of 0.05% during FY2019, and its lowest value of -9.50% during FY2017.
  • Its 3-year average for Return on Sales is -3.14%, with a median of 0.05% in 2018.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by 475bps in 2016, then skyrocketed by 955bps in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Return on Sales (Yearly) stood at -4.66% in 2015, then slumped by 475bps to -9.41% in 2016, then declined by 10bps to -9.50% in 2017, then skyrocketed by 955bps to 0.05% in 2018, then remained steady at 0.05% in 2019.